Written by: Ellie Pranckevicius, FNP-BC, Aesthetic Nurse Practitioner & Aesthetic Injector | Facial Restoration & Regenerative Injectable Specialist, Mirror Plastic Surgery
Key Takeaways
- Traditional GLP-1 agonists like semaglutide can cause 25-40% of weight loss to come from lean muscle mass, which increases sarcopenia risk and slows metabolism.1
- GLP-3R is a next-generation peptide that supports fat loss and insulin sensitivity while reducing muscle wasting compared to standard GLP-1 drugs.1
- When paired with exercise and nutrition, GLP-3R has been observed to produce 20-50% less lean mass loss than GLP-1 therapies, helping preserve strength and metabolic health.1
- Mirror Plastic Surgery offers concierge GLP-3R care with lab analysis, personalized dosing, peptide stacking, and 24/7 supervision by specialist Ellie Pranckevicius.
- Book a GLP-3R consultation at Mirror Plastic Surgery to pursue muscle-preserving weight loss with medical guidance.
Meet Your GLP-3R Specialist: Ellie Pranckevicius
Ellie Pranckevicius, FNP-BC, leads Mirror Plastic Surgery’s peptide therapy program with a blend of aesthetic expertise and advanced clinical training. She earned her Master’s in Nursing from the University of South Florida and spent four years in the Neuroscience ICU at Tampa General Hospital, where she developed deep experience in complex physiology and metabolic health. Her background as a licensed esthetician adds insight into body composition goals and aesthetic outcomes.
Ellie focuses on education and personalized care for every GLP-3R patient. She notes that her GLP-3R clients retain significantly more lean mass than traditional GLP-1 users in her practice.1 She attributes this to comprehensive lab analysis and tailored protocols that support muscle preservation while driving fat loss. Her concierge model includes detailed consultations, ongoing monitoring, and 24/7 support to promote safe and effective results.
How GLP-3R Differs From Traditional GLP-1 Therapies
GLP-3R is an advanced compounding peptide that shares some mechanisms with GLP-1 receptor agonists but offers distinct advantages for muscle preservation during weight loss. Traditional GLP-1 drugs work mainly through appetite suppression and delayed gastric emptying, which can push the body toward a more catabolic state. GLP-3R instead provides more targeted receptor activity with less impact on muscle tissue.
The key difference lies in GLP-3R’s support for insulin sensitivity and its lower tendency to drive muscle wasting. The European Atherosclerosis Society warns that rapid weight loss from traditional GLP-1 agonists may reduce muscle mass, which then requires strength training and adequate protein intake to prevent functional decline.1 GLP-3R’s formulation responds to these concerns through improved receptor selectivity and a gentler appetite effect that better supports muscle maintenance.
The following comparison highlights key differences in muscle impact, side effects, and clinical applications:
| Aspect | GLP-3R | GLP-1 |
|---|---|---|
| Muscle Impact | Reduced sarcopenia risk (compounding advances) | 25-40% lean loss |
| Side Effects | Fewer GI, more muscle-friendly profile | Nausea and more catabolic profile |
| Indications | Weight loss, metabolic support, cardiovascular risk factors | Diabetes and obesity |
Discover if GLP-3R’s targeted approach is right for your goals
How GLP-3R Supports Muscle Preservation
GLP-3R helps preserve muscle by supporting more balanced energy regulation and metabolism. Traditional GLP-1 agonists can trigger a strong catabolic state through severe appetite suppression, which often reduces both calories and protein intake. GLP-3R still promotes fat loss but does so while better maintaining the conditions needed for muscle protection.
Building on the strength training recommendations from the European Atherosclerosis Society, GLP-3R’s formulation pairs well with resistance training and adequate protein intake. This combination supports muscle protein synthesis while encouraging fat oxidation. Patients can pursue weight loss while still fueling their muscles.
These effects become most noticeable when GLP-3R is combined with structured nutrition and exercise plans. Clinical observations suggest that GLP-3R users experience less of the energy drop and protein intake decline that often appear with traditional GLP-1 therapies. This pattern helps maintain the metabolic environment required for muscle preservation during weight loss.
GLP-3R vs. GLP-1: Muscle Impact Comparison
GLP-3R’s advantages stand out when compared directly with traditional GLP-1 agonists. In clinical trials of semaglutide, 25-40% of total weight lost can come from lean mass, which aligns with the muscle loss rates mentioned earlier.1 In addition, Wilding et al. reported a 9.7% reduction in total lean mass from baseline, highlighting the scale of muscle change that can occur.1
These findings reflect how traditional GLP-1 agonists affect body composition. Traditional GLP-1 agonists induce a catabolic state by reducing appetite and caloric intake, which leads to muscle tissue breakdown along with fat loss. This pattern slows metabolism, reduces strength, and raises the risk of weight regain once treatment stops.
Early clinical observations with GLP-3R suggest a different trajectory. Patients may experience 20-50% less lean mass loss compared to traditional semaglutide protocols.1 These observations vary by baseline body composition, adherence to exercise, and nutritional support. GLP-3R’s more selective receptor activity appears to help maintain the metabolic conditions needed for muscle preservation while still supporting meaningful fat loss.
Mirror Plastic Surgery’s GLP-3R Protocols
Mirror Plastic Surgery starts each GLP-3R journey with a comprehensive 30-60 minute consultation with Ellie Pranckevicius. This visit covers detailed medical history, weight loss goals, and specific muscle preservation priorities. For a complete picture, Ellie orders or reviews lab panels that include thyroid function, liver and kidney markers, diabetes indicators, and hormone levels.
Ellie then designs a customized GLP-3R protocol based on these findings. Many plans include complementary peptides that further support muscle preservation. Common combinations pair GLP-3R with Sermorelin or Ipamorelin, which are growth hormone releasing peptides that support natural growth hormone production and muscle retention during weight loss.
The concierge care model begins with quality peptide sourcing from reputable providers that use rigorous batch testing to confirm purity and accurate dosing. This foundation of quality is supported by 24/7 access to Ellie via text message for ongoing support, questions, and protocol adjustments. To help patients safely self-administer, Ellie provides detailed administration instructions and video demonstrations that cover reconstitution and injection techniques. Because this level of care should be accessible beyond one city, remote service delivery allows patients across the United States to receive treatment through secure shipping and telemedicine follow-ups.
Book your GLP-3R consultation with Mirror Plastic Surgery
Evidence, Use Cases, and Patient Outcomes
Clinical experience with GLP-3R at Mirror Plastic Surgery shows encouraging results for muscle preservation during weight loss.1 Patients often report steady energy levels throughout treatment, which supports consistent training.1 Many also describe maintained or improved strength in the gym while their body weight decreases.1
Objective measures support these reports. DEXA scan follow-ups in select cases show preserved lean mass percentages compared to typical patterns seen in traditional GLP-1 users.1 Together, these subjective and objective findings suggest that GLP-3R can support higher quality weight loss that favors fat reduction over muscle loss.1
Industry forecasts highlight growing demand for therapies that improve the quality of weight loss by reducing lean mass loss, especially for older adults with obesity. GLP-3R fits within this emerging focus on protecting muscle while addressing metabolic risk.
Post-surgical patients working with Dr. Akash Chandawarkar have also used GLP-3R protocols to help maintain surgical results. These patients often achieve additional body contouring through fat loss while preserving muscle definition.1 Individual results still vary based on genetics, lifestyle, adherence to protocols, and baseline health status.
Risks, Safety, and Considerations
GLP-3R, like other compounding peptides, is not FDA-regulated, so medical supervision remains essential. Mirror Plastic Surgery reduces risk through careful pre-treatment evaluation, ongoing lab monitoring, and regular check-ins to review response and adjust protocols.
Potential side effects can include mild gastrointestinal symptoms, injection site reactions, and individual differences in how patients respond. The muscle-wasting risk seen with traditional GLP-1 agonists appears lower with GLP-3R, yet proper nutrition and exercise still play a central role in outcomes. Ellie’s monitoring protocols help detect and address any concerning shifts in body composition or metabolic markers early.
Frequently Asked Questions
Does GLP-3R preserve muscle better than semaglutide?
GLP-3R appears to preserve muscle more effectively than traditional semaglutide therapy.1 While semaglutide users often see 25-40% of weight loss come from muscle tissue, early observations with GLP-3R point to significantly lower lean mass loss when patients follow appropriate nutrition and exercise plans.1
What are GLP-3R side effects on muscle?
GLP-3R shows minimal direct muscle-wasting effects compared to traditional GLP-1 agonists.1 Its formulation specifically addresses the catabolic pathways that contribute to muscle breakdown with semaglutide and similar medications. Most patients maintain strength and energy during treatment, although responses differ between individuals.1 Regular lab work and body composition assessments help confirm that muscle mass stays protected throughout therapy.
How does Mirror ensure safe GLP-3R use?
Mirror Plastic Surgery supports safe GLP-3R use through a structured concierge model. Ellie begins with comprehensive pre-treatment lab analysis and a detailed consultation to assess candidacy. She then develops a personalized protocol based on each patient’s health profile and goals. Quality sourcing from vetted providers with batch testing supports product safety, while 24/7 support and scheduled monitoring visits help refine treatment and address concerns quickly.
Can GLP-3R be stacked for muscle protection?
GLP-3R can be combined with other peptides to enhance muscle preservation. Many patients use growth hormone releasing peptides such as Sermorelin or Ipamorelin alongside GLP-3R. These combinations support natural growth hormone production and muscle retention. Ellie designs each stack based on individual goals, lab data, and treatment response, with ongoing monitoring to maintain safety and effectiveness.
Is GLP-3R right for me?
GLP-3R suitability depends on your health status, weight loss goals, and priorities around muscle preservation. Ideal candidates often include people who lost muscle on traditional GLP-1 therapies, fitness enthusiasts who want fat loss without sacrificing strength, and individuals with metabolic concerns who need supervised peptide therapy. A personalized consultation with full lab analysis helps determine whether GLP-3R matches your needs and health profile.
Conclusion
GLP-3R offers a meaningful advancement in peptide-based weight loss by pairing the metabolic benefits of GLP-1 agonists with stronger protection for lean muscle. Its more selective receptor activity and reduced catabolic impact make it a strong option for people who want sustainable fat loss without sacrificing strength or long-term metabolic health.
Mirror Plastic Surgery delivers GLP-3R therapy through a concierge model that emphasizes safety, personalization, and close follow-up. Under the guidance of Ellie Pranckevicius, patients receive comprehensive evaluation, tailored protocols, and continuous medical oversight in this evolving area of care.
Schedule your personalized GLP-3R consultation
Disclaimer: This information is for educational purposes only and does not constitute medical advice. Results may vary between individuals. GLP-3R is not FDA-approved. Consult with qualified healthcare professionals before beginning any peptide therapy. Information reflects current understanding as of 2026 and may change as research evolves.
1 Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.
Peptide therapy is intended for wellness and optimization purposes and is not prescribed to diagnose, treat, cure, or prevent disease unless specifically stated. Many peptides are not FDA-approved and may be used off-label. Some have limited long-term safety data, with a potential for unknown risks, complications, or desensitization with prolonged use.
